Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares Repurchased
Ratios

Core Laboratories (CLB) Receivables - Other (2022 - 2025)

Core Laboratories filings provide 4 years of Receivables - Other readings, the most recent being $1.2 million for Q3 2025.

  • On a quarterly basis, Receivables - Other rose 98.63% to $1.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.2 million, a 98.63% increase, with the full-year FY2024 number at $370000.0, down 71.38% from a year prior.
  • Receivables - Other hit $1.2 million in Q3 2025 for Core Laboratories, up from $246000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.3 million in Q4 2023 to a low of $246000.0 in Q2 2025.
  • Median Receivables - Other over the past 4 years was $911000.0 (2024), compared with a mean of $835090.9.
  • Biggest five-year swings in Receivables - Other: skyrocketed 114.94% in 2024 and later crashed 77.2% in 2025.
  • Core Laboratories' Receivables - Other stood at $1.1 million in 2022, then grew by 12.63% to $1.3 million in 2023, then crashed by 71.38% to $370000.0 in 2024, then skyrocketed by 214.05% to $1.2 million in 2025.
  • The last three reported values for Receivables - Other were $1.2 million (Q3 2025), $246000.0 (Q2 2025), and $760000.0 (Q1 2025) per Business Quant data.